Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2006-05-18 09:20:41 UTC |
---|
Update Date | 2022-03-07 02:49:11 UTC |
---|
HMDB ID | HMDB0001944 |
---|
Secondary Accession Numbers | - HMDB0004994
- HMDB01944
- HMDB04994
|
---|
Metabolite Identification |
---|
Common Name | Chlorpheniramine |
---|
Description | Chlorpheniramine is a histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than Promethazine. -- Pubchem; Chlorphenamine or chlorpheniramine, commonly marketed as its salt chlorphenamine maleate (Chlor- Trimeton, Piriton, Chlor- Tripolon), is a first generation antihistamine used in the prevention of the symptoms of allergic conditions such as rhinitis and urticaria.- wikipedia. |
---|
Structure | CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1 InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
1-(p-Chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane | ChEBI | 1-(p-Chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine | ChEBI | 2-[p-Chloro-alpha-[2-(dimethylamino)ethyl]benzyl]pyridine | ChEBI | 3-(p-Chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine | ChEBI | Chlorophenylpyridamine | ChEBI | Chlorphenamin | ChEBI | Chlorphenaminum | ChEBI | Chlorpheniraminum | ChEBI | Clofeniramina | ChEBI | Clorfenamina | ChEBI | Clorfeniramina | ChEBI | gamma-(4-Chlorophenyl)-gamma-(2-pyridyl)propyldimethylamine | ChEBI | gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine | ChEBI | Haynon | ChEBI | Chlorphenamine | Kegg | 2-[p-Chloro-a-[2-(dimethylamino)ethyl]benzyl]pyridine | Generator | 2-[p-Chloro-α-[2-(dimethylamino)ethyl]benzyl]pyridine | Generator | g-(4-Chlorophenyl)-g-(2-pyridyl)propyldimethylamine | Generator | Γ-(4-chlorophenyl)-γ-(2-pyridyl)propyldimethylamine | Generator | g-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine | Generator | Γ-(4-chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine | Generator | Chlor-trimeton | HMDB | Chloropheniramine maleate | HMDB | Chlorphenamine hydrogen maleate | HMDB | Chlorphenamine maleate | HMDB | Chlorpheniaramine maleate | HMDB | Chlorpheniramine maleate | HMDB | Teldrin | HMDB | Aller-chlor | HMDB | Chlor-tripolon | HMDB | Chlorpro | HMDB | Cloro-trimeton | HMDB | Kloromin | HMDB | Maleate, chlorpheniramine | HMDB | Piriton | HMDB | Rugby brand OF chlorpheniramine maleate | HMDB | Schering-plough brand OF chlorpheniramine maleate | HMDB | Tannate, chlorpheniramine | HMDB | Bayer brand OF chlorpheniramine maleate | HMDB | Chlo-amine | HMDB | Hogil brand 1 OF chlorpheniramine maleate | HMDB | Llorens brand OF chlorpheniramine maleate | HMDB | Schering brand OF chlorpheniramine maleate | HMDB | Vortech brand 1 OF chlorpheniramine maleate | HMDB | Antihistaminico llorens | HMDB | Chlorprophenpyridamine | HMDB | Chlorspan 12 | HMDB | Chlortab-4 | HMDB | Halsey drug brand OF chlorpheniramine maleate | HMDB | Stafford-miller brand OF chlorpheniramine maleate | HMDB | Vortech brand 3 OF chlorpheniramine maleate | HMDB | Chlor-100 | HMDB | Chlorpheniramine tannate | HMDB | Efidac 24 | HMDB | Hogil brand 2 OF chlorpheniramine maleate | HMDB | Intra brand OF chlorpheniramine maleate | HMDB | Schein brand OF chlorpheniramine maleate | HMDB | Vortech brand 2 OF chlorpheniramine maleate | HMDB |
|
---|
Chemical Formula | C16H19ClN2 |
---|
Average Molecular Weight | 274.788 |
---|
Monoisotopic Molecular Weight | 274.123676325 |
---|
IUPAC Name | [3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine |
---|
Traditional Name | chlorpheniramine |
---|
CAS Registry Number | 113-92-8 |
---|
SMILES | CN(C)CCC(C1=CC=C(Cl)C=C1)C1=CC=CC=N1 |
---|
InChI Identifier | InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3 |
---|
InChI Key | SOYKEARSMXGVTM-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pheniramines. Pheniramines are compounds containing a pheniramine moiety, which is structurally characterized by the presence of a 2-benzylpyridine linked to an dimethyl(propyl)amine to form a dimethyl[3-phenyl-3-(pyridin-2-yl)propyl]amine skeleton. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Pheniramines |
---|
Direct Parent | Pheniramines |
---|
Alternative Parents | |
---|
Substituents | - Pheniramine
- Chlorobenzene
- Halobenzene
- Aralkylamine
- Aryl chloride
- Benzenoid
- Monocyclic benzene moiety
- Aryl halide
- Heteroaromatic compound
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organic nitrogen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 130 - 135 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 160 mg/mL at 25 °C | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.87 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 9.9383 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.62 minutes | 32390414 | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 88.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Chlorpheniramine EI-B (Non-derivatized) | splash10-0zfr-6290000000-2ca3230cde716588805e | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Chlorpheniramine EI-B (Non-derivatized) | splash10-0zfr-6290000000-2ca3230cde716588805e | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Chlorpheniramine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9380000000-f4a0f7b13adeafb1762d | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Chlorpheniramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Chlorpheniramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Chlorpheniramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0zfr-6490000000-8e58cd1c686f23a7dac6 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlorpheniramine Quattro_QQQ 10V, N/A-QTOF (Annotated) | splash10-01b9-3900000000-ea4ccfd2afe05f49fc7a | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlorpheniramine Quattro_QQQ 25V, N/A-QTOF (Annotated) | splash10-004i-0090000000-9e46eb080de95d4f8f8e | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlorpheniramine Quattro_QQQ 40V, N/A-QTOF (Annotated) | splash10-014i-1920000000-d2d2acf559d9070a1d47 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlorpheniramine EI-B (Unknown) , Positive-QTOF | splash10-0zfr-6190000000-2ca3230cde716588805e | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlorpheniramine LC-ESI-qTof , Positive-QTOF | splash10-0uy0-0960000000-1f750af75fe542c6c06f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlorpheniramine , positive-QTOF | splash10-001i-0290000000-03651b7b90a1745fdf23 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlorpheniramine , positive-QTOF | splash10-0uy0-0960000000-1f750af75fe542c6c06f | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Chlorpheniramine 35V, Positive-QTOF | splash10-001i-0490000000-3d28aeb0e77391e8e9b2 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 10V, Positive-QTOF | splash10-004i-0090000000-9b4d486e9c2c7712ca4d | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 20V, Positive-QTOF | splash10-0059-0190000000-2c96b165338a445b284d | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 40V, Positive-QTOF | splash10-0ue9-3960000000-73025748bd5a00459938 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 10V, Negative-QTOF | splash10-00di-0090000000-90a6e640c735788d17ca | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 20V, Negative-QTOF | splash10-00di-1090000000-89ac3cf688134ba8a50b | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 40V, Negative-QTOF | splash10-01tc-6490000000-4242ef7cec7b0b0a7393 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 10V, Positive-QTOF | splash10-001i-0090000000-c38223f80e776a39c840 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 20V, Positive-QTOF | splash10-001i-0090000000-5c9ac02f7374772460c8 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 40V, Positive-QTOF | splash10-0ue9-1290000000-cc70655f6b19de3dc41d | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 10V, Negative-QTOF | splash10-00di-0090000000-df52e539d08e1efa7d95 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 20V, Negative-QTOF | splash10-00di-4390000000-4b1316bcb291af4998c9 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Chlorpheniramine 40V, Negative-QTOF | splash10-0ue9-8490000000-4bf6d67eb7d38a21b96b | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
General References | - Bantz EW, Dolen WK, Chadwick EW, Nelson HS: Chronic chlorpheniramine therapy: subsensitivity, drug metabolism, and compliance. Ann Allergy. 1987 Nov;59(5):341-6. [PubMed:3688558 ]
- Simons FE, Silver NA, Gu X, Simons KJ: Clinical pharmacology of H1-antihistamines in the skin. J Allergy Clin Immunol. 2002 Nov;110(5):777-83. [PubMed:12417888 ]
- MSDS [Link]
|
---|